Photocure ASA: Clinical and cost impact analysis shows beneficial impact of replacing current surgical modalities with Cevira®
A poster demonstrating the clinical and cost impact of Cevira® was presented at the ISPOR European congress in Glasgow, Scotland, November 4-8, 2017. The budget impact model from a US payer perspective shows beneficial impact of replacing the current surgical modalities, LEEP and cold knife conization, with Cevira®. Photocure ASA announced today that a poster on the clinical and cost impact of Cevira[®] from a US payer perspective was presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20[th] Annual European Congress, Glasgow, Scotland, November 4-8,